Five hundred people in the Canadian province of New Brunswick were diagnosed with a "mystery brain disorder" that resembled ...

Researchers at Rutgers Robert Wood Johnson Medical School in New Brunswick are enrolling participants in the National ...

There are indications that a simple finger-prick blood test could, in the future, detect Alzheimer's disease long before the ...

A large McGill University study has found that two classes of medications commonly prescribed for type 2 diabetes, both ...

Updated guidance on vascular cognitive impairment emphasizes executive function and processing speed, endorses brief, ...

Despite longstanding guidelines, many dementia patients are still prescribed brain-altering medications that can raise the ...

The study also leveraged advanced diagnostic tools to identify early biomarkers of cognitive decline in individuals with a ...

Neumora Therapeutics’ oral Alzheimer’s disease agitation drug has shown benefit, reducing agitation, in a Phase Ib trial.

The authors of the study, published in Cell Reports Medicine, are optimistic that it could pave the way for potential ...

Funds to support ongoing Phase 1 trial of MNA-001 and validation of translational biomarkers for TREM2 function in Alzheimer's Work will inform Phase 2 trials assessing the potential of MNA-001 to ...

A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both ...

As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate ...